DoorDash Price Target Cuts Hit Stock as Q2 Outlook Improves
Two top analysts trimmed DoorDash price targets after the company posted solid Q1 results, while signaling a brighter...
Which Travel Cards Have No Annual Fees
Curious about which travel cards have no annual fees? Find the best options to maximize your travel rewards.
26,591 articles
Raymond James Just Upgraded Fastly to Outperform on AI
Raymond James just upgraded Fastly to Outperform with a $23 price target after a sharp one-day drop, pointing to AI-d...
Arteris Director Trims Stake: Insider Move Impact Today
When a board member sells shares, investors watch closely. This article unpacks a recent Arteris insider move, what i...
Investors: Watch These Macro Triggers Before Summer 2026
EMB holds near the high end of its range as volatility fades, but a shift in the 10-year yield, policy signals, or EM...
Ducommun (DCO) 2026 Earnings: Q1 Review and Outlook
Investors are focused on ducommun (dco) 2026 earnings as Q1 sets the tone for the year. This article explains how to ...
Veru (Veru) 2026 Earnings: What to Watch Now
This deep-dive breaks down veru (veru) 2026 earnings, translating the quarterly numbers into a clear sense of cash he...
Renovo Secures $74.5M Investment-Grade Note Financing
Renovo Management closed two senior secured notes totaling $74.5 million, earning investment-grade ratings. The deal ...
Citi Cuts Lucid Price Target as Q1 Miss Rocks Shares
Citi lowers Lucid's price target to $14 following a disappointing Q1 2026 and the withdrawal of 2026 guidance, while ...
Under Greg Abel, Apple Stock Stays Put in Berkshire Portfolio
Berkshire Hathaway's latest moves under Greg Abel show a shift toward stability with Apple while betting bigger on Al...
Google Brings Real Estate Listings Back to Mobile Search
Google reopens mobile real estate listings in a growing pilot, delivering property pages, tour requests and agent con...
UnitedHealth Price Target Lifted as Managed Care Storm Clears
Mizuho ups UnitedHealth's price target to $440, citing easing medical loss ratio pressures and a turning Medicare Adv...
Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status